摘要 : The in vitro activities of garenoxacin, a novel des-F (6)-quinolone, levofloxacin, moxifloxacin and clarithromycin were tested against 30 recent clinical isolates of Chlamydia pneumoniae. The minimal inhibitory concentration (MIC)... 展开
作者 | Roblin PM. Reznik T. Hammerschlag MR. |
---|---|
期刊名称 | 《International journal of antimicrobial agents》 |
总页数 | 3 |
语种/中图分类号 | 英语 / R978.1 |
关键词 | Chlamydia pneumoniae Garenoxacin Mic Fluoroquinolones Bms-284756 Quinolone Legionella |
馆藏号 | N2008EPST0000876 |